Novocure (NVCR) Misses Q3 EPS by 6c

Novocure (NASDAQ: NVCR) reported Q3 EPS of ($0.13), $0.06 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $133.6 million versus the consensus estimate of $141.76 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Ennis (EBF) Reports In-Line Q1 EPS
• Deutsche Bank Starts DexCom (DXCM) at Buy